葛兰素史克洽谈收购生物科技公司IDRx,接近就潜在的10亿美元交易达成共识。
RSV疫苗再遭“打击”。 日前,FDA 发布公告,要求辉瑞和GSK对其已被批准上的RSV疫苗的标签进行修改,添加有关吉兰-巴雷综合征风险的新警告。 CSO企业在制药的路上越走越远。 1月8日,康哲药业宣布,通过全资附属公司与Alpha ...
DDN, which calls itself “a global leader in AI and data intelligence solutions,” announced it has received a $300M investment from funds ...
GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related ...